90 related articles for article (PubMed ID: 1875045)
1. In vitro cutaneous biotransformation of propranolol.
Cormier M; Ledger PW; Marty JP; Amkraut A
J Invest Dermatol; 1991 Sep; 97(3):447-53. PubMed ID: 1875045
[TBL] [Abstract][Full Text] [Related]
2. Side-chain metabolism of propranolol: involvement of monoamine oxidase and mitochondrial aldehyde dehydrogenase in the metabolism of N-desisopropylpropranolol to naphthoxylactic acid in rat liver.
Imamura Y; Wu X; Noda A; Noda H
Life Sci; 2002 Apr; 70(22):2687-97. PubMed ID: 12269395
[TBL] [Abstract][Full Text] [Related]
3. Influence of aging on the oxidative and conjugative metabolism of propranolol.
Tateishi T; Fujimura A; Shiga T; Ohashi K; Ebihara A
Int J Clin Pharmacol Res; 1995; 15(3):95-101. PubMed ID: 8847155
[TBL] [Abstract][Full Text] [Related]
4. Fetal hepatic propranolol metabolism. Studies in the isolated perfused fetal sheep liver.
Ring JA; Ghabrial H; Ching MS; Shulkes A; Smallwood RA; Morgan DJ
Drug Metab Dispos; 1995 Feb; 23(2):190-6. PubMed ID: 7736910
[TBL] [Abstract][Full Text] [Related]
5. Effect of dose and uremia on plasma and urine profiles of propranolol metabolites.
Schneck DW; Pritchard JF; Gibson TP; Vary JE; Hayes AH
Clin Pharmacol Ther; 1980 Jun; 27(6):744-55. PubMed ID: 7379441
[TBL] [Abstract][Full Text] [Related]
6. Side-chain metabolism of propranolol: involvement of monoamine oxidase and aldehyde reductase in the metabolism of N-desisopropylpropranolol to propranolol glycol in rat liver.
Wu X; Noda A; Noda H; Imamura Y
Comp Biochem Physiol C Toxicol Pharmacol; 2001 Aug; 129(4):361-8. PubMed ID: 11489433
[TBL] [Abstract][Full Text] [Related]
7. N-dealkylation of propranolol in rat, dog, and man. Chemical and stereochemical aspects.
Nelson WL; Bartels MJ
Drug Metab Dispos; 1984; 12(3):345-52. PubMed ID: 6145562
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and identification of 3-(4-hydroxy-1-naphthoxy)lactic acid as a metabolite of propranolol in the rat, in man, and in the rat liver 9000 g supernatant fraction.
Talaat RE; Nelson WL
Drug Metab Dispos; 1986; 14(2):202-7. PubMed ID: 2870895
[TBL] [Abstract][Full Text] [Related]
9. Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts.
Gysler A; Lange K; Korting HC; Schäfer-Korting M
Pharm Res; 1997 Jun; 14(6):793-7. PubMed ID: 9210199
[TBL] [Abstract][Full Text] [Related]
10. Product inhibition and dose-dependent bioavailability of propranolol in the isolated perfused rat liver preparation.
Ghabrial H; Nand R; Stead CK; Smallwood RA; Morgan DJ
J Pharm Sci; 1994 Jul; 83(7):931-6. PubMed ID: 7965671
[TBL] [Abstract][Full Text] [Related]
11. Chemical trapping of labile aldehyde intermediates in the metabolism of propranolol and oxprenolol.
Goldszer F; Tindell GL; Walle UK; Walle T
Res Commun Chem Pathol Pharmacol; 1981 Nov; 34(2):193-205. PubMed ID: 7335950
[TBL] [Abstract][Full Text] [Related]
12. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.
Marathe PH; Shen DD; Nelson WL
Drug Metab Dispos; 1994; 22(2):237-47. PubMed ID: 8013280
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of propranolol during percutaneous absorption in human skin.
Ademola JI; Chow CA; Wester RC; Maibach HI
J Pharm Sci; 1993 Aug; 82(8):767-70. PubMed ID: 8377110
[TBL] [Abstract][Full Text] [Related]
14. A preliminary study of growth characteristics of melanocytes co-cultured with keratinocytes in vitro.
Zhang C; Zhou L; Huang J; Mei X; Wu Z; Shi W
J Cell Biochem; 2018 Jul; 119(7):6173-6180. PubMed ID: 29637612
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of 3,4-didehydroretinol from retinol by human skin keratinocytes in culture.
Rollman O; Wood EJ; Olsson MJ; Cunliffe WJ
Biochem J; 1993 Aug; 293 ( Pt 3)(Pt 3):675-82. PubMed ID: 8352734
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous xenobiotic metabolism: glycine conjugation in human and rat keratinocytes.
Nasseri-Sina P; Hotchkiss SA; Caldwell J
Food Chem Toxicol; 1997; 35(3-4):409-16. PubMed ID: 9207903
[TBL] [Abstract][Full Text] [Related]
17. Potent inhibition of MAO mediated propranolol metabolism by dimethyl sulfoxide in Hep G2 cells.
Steiner A; Walle T
Res Commun Chem Pathol Pharmacol; 1992 Mar; 75(3):373-6. PubMed ID: 1509206
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase.
Masubuchi Y; Hosokawa S; Horie T; Suzuki T; Ohmori S; Kitada M; Narimatsu S
Drug Metab Dispos; 1994; 22(6):909-15. PubMed ID: 7895609
[TBL] [Abstract][Full Text] [Related]
19. Expression of Bcl-2 and Bax in cultured normal human keratinocytes and melanocytes: relationship to differentiation and melanogenesis.
Sermadiras S; Dumas M; Joly-Berville R; Bonté F; Meybeck A; Ratinaud MH
Br J Dermatol; 1997 Dec; 137(6):883-9. PubMed ID: 9470903
[TBL] [Abstract][Full Text] [Related]
20. Decreased absorption as a possible cause for the lower bioavailability of a sustained-release propranolol.
Takahashi H; Ogata H; Warabioka R; Kashiwada K; Ohira M; Someya K
J Pharm Sci; 1990 Mar; 79(3):212-5. PubMed ID: 2338628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
